Mancini Marianna
Insider CIK 1838112 · VKTX Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-07-29 | 2026-07-29 | 18,217 | $33.47 | $609.7K | 422,760 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-07-29 | 2026-07-29 | 18,217 | $33.47 | $609.6K | 422,760 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-07-28 | 2026-07-29 | 31,667 | — | $0 | 440,977 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-07-28 | 2026-07-29 | 31,667 | — | $0 | 440,977 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 1,600 | $35.07 | $56.1K | 409,190 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 10,500 | $34.22 | $359.3K | 410,790 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 13,600 | $33.37 | $453.8K | 421,290 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 31,961 | $32.29 | $1.03M | 434,890 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 91,000 | — | $0 | 91,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 32,049 | — | $0 | 466,851 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 41,000 | — | $0 | 434,802 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 6,185 | $35.00 | $216.5K | 382,467 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-10-27 | 2025-10-28 | 11,117 | — | $0 | 388,652 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-07-03 | 2025-07-03 | 4,266 | $27.77 | $118.5K | 377,535 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-07-02 | 2025-07-03 | 7,667 | — | $0 | 381,801 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-01-06 | 2025-01-06 | 5,100 | $43.32 | $220.9K | 374,134 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-01-06 | 2025-01-06 | 49,115 | $42.69 | $2.10M | 379,234 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 37,200 | — | $0 | 37,200 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-01-03 | 2025-01-06 | 44,533 | — | $0 | 406,682 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-01-03 | 2025-01-06 | 21,667 | — | $0 | 428,349 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-07-30 | 2024-07-31 | 3,322 | $57.82 | $192.1K | 362,149 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-07-30 | 2024-07-31 | 14,704 | $56.98 | $837.8K | 365,471 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-07-29 | 2024-07-31 | 21,667 | — | $0 | 380,175 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-07-29 | 2024-07-31 | 10,000 | — | $0 | 358,508 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-05-01 | 2024-05-02 | 87,000 | — | $0 | 87,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-05-01 | 2024-05-02 | 35,426 | — | $0 | 18,574 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-05-01 | 2024-05-02 | 51,000 | — | $0 | 153,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-05-01 | 2024-05-02 | 90,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-05-01 | 2024-05-02 | 17,999 | — | $0 | 1 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-05-01 | 2024-05-02 | 17,999 | $4.68 | $84.2K | 366,507 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-05-01 | 2024-05-02 | 87,000 | $4.88 | $424.6K | 453,507 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-05-01 | 2024-05-02 | 119,946 | $79.29 | $9.51M | 354,756 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-05-01 | 2024-05-02 | 6,248 | $80.08 | $500.3K | 348,508 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-05-01 | 2024-05-02 | 90,000 | $5.80 | $522.0K | 543,507 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-05-01 | 2024-05-02 | 105,343 | $78.65 | $8.29M | 474,702 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-05-01 | 2024-05-02 | 26,142 | $77.49 | $2.03M | 580,045 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-05-01 | 2024-05-02 | 23,746 | $76.40 | $1.81M | 606,187 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-05-01 | 2024-05-02 | 51,000 | $8.52 | $434.5K | 629,933 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-05-01 | 2024-05-02 | 35,426 | $7.77 | $275.3K | 578,933 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-03-27 | 2024-03-27 | 31,667 | — | $0 | 380,175 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-03-27 | 2024-03-27 | 16,610 | $83.34 | $1.38M | 363,565 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-04 | 31,667 | — | $0 | 365,466 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-04 | 16,958 | $85.22 | $1.45M | 348,508 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-01-04 | 2024-01-04 | 14,199 | $18.58 | $263.8K | 333,799 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2024-01-03 | 2024-01-04 | 155,000 | — | $0 | 155,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-01-03 | 2024-01-04 | 70,000 | — | $0 | 380,675 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-01-03 | 2024-01-04 | 32,677 | $17.40 | $568.6K | 347,998 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-01-03 | 2024-01-04 | 16,533 | $17.40 | $287.7K | 310,675 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-01-03 | 2024-01-04 | 28,334 | — | $0 | 327,208 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-17 | 2023-04-18 | 12,500 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-17 | 2023-04-18 | 12,500 | $13.07 | $163.4K | 300,263 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-04-17 | 2023-04-18 | 12,500 | $20.00 | $250.0K | 287,763 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-30 | 2023-04-03 | 23,100 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-30 | 2023-04-03 | 10,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-30 | 2023-04-03 | 3,000 | — | $0 | 1,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2023-03-30 | 2023-04-03 | 56,667 | — | $0 | 318,562 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 36,100 | $17.01 | $614.1K | 261,895 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-03-30 | 2023-04-03 | 30,799 | $17.57 | $541.1K | 287,763 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 10,000 | $7.69 | $76.9K | 294,995 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 23,100 | $8.52 | $196.8K | 284,995 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 3,000 | $6.47 | $19.4K | 297,995 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-29 | 2023-03-30 | 15,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-29 | 2023-03-30 | 15,000 | $9.13 | $136.9K | 303,137 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-03-29 | 2023-03-30 | 41,242 | $16.00 | $659.9K | 261,895 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-28 | 2023-03-30 | 53,054 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-28 | 2023-03-30 | 15,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-28 | 2023-03-30 | 4,873 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-28 | 2023-03-30 | 15,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-28 | 2023-03-30 | 15,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-28 | 2023-03-30 | 10,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-28 | 2023-03-30 | 24,500 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-28 | 2023-03-30 | 30,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-28 | 2023-03-30 | 4,873 | $1.88 | $9.2K | 337,146 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-28 | 2023-03-30 | 10,000 | $1.04 | $10.4K | 430,200 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-28 | 2023-03-30 | 15,000 | $2.15 | $32.3K | 332,273 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-28 | 2023-03-30 | 53,054 | $1.23 | $65.3K | 405,200 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-28 | 2023-03-30 | 15,000 | $1.08 | $16.2K | 420,200 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-28 | 2023-03-30 | 15,000 | $1.26 | $18.9K | 352,146 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-28 | 2023-03-30 | 24,500 | $4.65 | $113.9K | 454,700 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-28 | 2023-03-30 | 30,000 | $4.37 | $131.1K | 484,700 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-03-28 | 2023-03-30 | 196,563 | $15.00 | $2.95M | 288,137 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-01-15 | 2023-01-17 | 1,079 | $8.95 | $9.7K | 317,273 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-01-04 | 2023-01-04 | 13,994 | $8.42 | $117.8K | 318,352 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-04 | 204,000 | — | $0 | 204,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2023-01-03 | 2023-01-04 | 90,667 | — | $0 | 351,200 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-01-03 | 2023-01-04 | 18,854 | $8.52 | $160.6K | 332,346 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-12-30 | 2023-01-04 | 12,773 | $9.40 | $120.1K | 260,533 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2022-12-30 | 2023-01-04 | 23,500 | — | $0 | 273,306 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-01-15 | 2022-02-11 | 827 | $4.24 | $3.5K | 238,695 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-01-04 | 2022-01-05 | 11,845 | $4.62 | $54.7K | 239,522 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 174,000 | — | $0 | 174,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2022-01-03 | 2022-01-05 | 77,333 | — | $0 | 251,367 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-01-03 | 2022-01-05 | 3,919 | $4.88 | $19.1K | 174,034 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-09-28 | 2021-09-30 | 2,839 | $6.50 | $18.5K | 177,535 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-09-28 | 2021-09-30 | 6,667 | — | $0 | 180,374 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-19 | 2021-01-19 | 994 | $6.68 | $6.6K | 169,952 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-15 | 2021-01-19 | 686 | $6.48 | $4.4K | 170,946 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-01-04 | 2021-01-06 | 6,750 | — | $0 | 174,405 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-04 | 2021-01-06 | 2,773 | $5.80 | $16.1K | 171,632 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-01-04 | 2021-01-06 | 73,000 | — | $0 | 167,655 | SEC↗ |